Minor RAS
MINOR
the mean USS of the 11 minor RAS subjects before treatment was 31 ± 3.3 (range of 25–36). After 3 months treatment, there was significant improvement of the USS by 20.3% with a further significant reduction in the mean USS at 6 months (p < 0.001), but no further statistically significant improvements thereafter (Table 